Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.
Revenue projections:
Revenue projections for CLEAN Clean Science and Technology Limited's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.
Financial Ratios:
currentRatio
5.136000
forwardPE
35.414295
debtToEquity
0.150000
earningsGrowth
0.055000
revenueGrowth
0.159000
grossMargins
0.637190
operatingMargins
0.331240
trailingEps
24.940000
forwardEps
35.090000
Clean Science and Technology Limited's current ratio of 5.136 reflects its strong liquidity position. The company has enough cash reserves and current assets to service its short-term debt obligations, signaling that Clean Science and Technology Limited is financially well-prepared to meet its liabilities without difficulty. Clean Science and Technology Limited's positive gross and operating margins reflect its ability to generate profits from operations. These margins demonstrate efficient cost control and profitability, indicating strong financial health for the company. CLEAN's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that CLEAN is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.
Price projections:
Price projections for CLEAN Over time, CLEAN's price projections have steadily declined, reflecting reduced confidence in the company's future performance. The downward revisions suggest analysts are becoming more conservative in their assessments.
Recommendation changes over time:
Recommendations trend for CLEAN
A recent buy bias from analysts toward CLEAN indicates strong confidence in the stock's future performance. This could encourage investors to park their money in CLEAN, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth examination of the factors contributing to the U.S. dollar's multi-year...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.